Search database
Filter
3127
Text search: drug supply
Featured
Language
Document type
1933
435
400
139
117
40
34
16
5
5
1
1
1
Countries
229
111
106
96
88
75
75
68
67
67
67
65
61
56
56
52
51
41
36
34
31
30
28
27
26
26
26
25
24
21
20
16
15
14
14
13
12
12
11
11
10
9
9
9
8
8
8
8
7
7
7
6
6
6
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
383
172
113
90
76
69
66
61
49
24
23
21
19
19
18
17
17
17
17
16
16
16
15
15
15
14
14
14
14
13
13
13
12
12
11
11
11
11
10
10
10
10
10
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1488
282
146
127
75
60
43
1
1
1
Toolboxes
282
260
163
160
154
140
82
72
54
52
48
47
44
33
28
19
19
17
15
14
12
7
6
1
 Add to my MEDBOX

Guideline for Adverse Drug Events Monitoring (Pharmacovigilance), Ethiopia

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2014) C1
3rd edition
 Download
  View PDF
 Add to my MEDBOX

Drugs and Drug Control in Namibia

Kazembe, L.N. & Neema, I. (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended

World Health Organization WHO (2017) C_WHO
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an ... more
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES ON DRUG REGISTRATION APPLICATIONS IN BOTSWANA, 4th edition

Ministry of Health, Gabarone, Botswana (2014)
 Download
  View PDF
 Add to my MEDBOX

Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB

World Health Organization Europe (2016) C_WHO
Results of the first national survey, 2013–2014
 Download
  View PDF
 Add to my MEDBOX

Infection prevention, control and surveillance: Limiting the development and spread of drug-resistance

O’Neill, J. Review on Antimicrobial Resistance (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1
 Add to my MEDBOX

Securing the future from drug-resistant infections

Interagency Coordination Group on Antimicrobial Resistance IAGG World Health Organisation WHO (2019) C_WHO
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
 Add to my MEDBOX

Maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic (Arabic Version)

World Health Organization WHO (2021) C_WHO
: interim guidance, 17 February 2021 This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding ... more
 Download
  View PDF
 Add to my MEDBOX

WHO recommendations on drug treatment for non-severe hypertension in pregnancy
recommended

World Health Organization WHO (2020) C_WHO
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi ... more
 External Link
 Add to my MEDBOX

Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures

World Health Organization WHO (2016) C_WHO
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India + Annexures

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare (2012) C1
 Download
  View PDF
 Add to my MEDBOX

Zambia: Guidelines for the programmatic Management of Drug-Resistant Tuberculosis

National TBLeprosy Control Programme, Ministry of Health, Zambia (2013) C1
 External Link
 Add to my MEDBOX

Operational Guidelines for the Management of Drug Resistant TB in Tanzania
recommended

Ministry of Health and Social Welfare, The United Republic of Tanzania (2012) C1
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan (2012) CC
Revised National Tuberculosis Control Programme
 Add to my MEDBOX

Guidelines for the Management of Drug Resistant Tuberculosis in Kenya

Ministry of Public Health and Sanitation, Kenya (2010) CC
 Download
  View PDF
 Add to my MEDBOX

Guidelines on programmatic management of drug resistant tuberculosis in Ethiopia
recommended

Ministry of Health Ethiopia (2014) CC
2nd edition
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 up-date

H. Schünemann, S.T. Aung, F. Bonsu et al. World Health Organisation (WHO) (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Global action plan on HIV drug resistance 2017–2021

World Health Organization (WHO) (2017) C_WHO
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ... more
 Download
  View PDF
 Add to my MEDBOX

Expansion Plan of Programmatic Management of Drug Resistant TB (PMDT)

National TB Control Programme, Bangladesh World Health Organization WHO, Bangladesh (2013) C1
 Download
  View PDF
 Add to my MEDBOX

HIV Programme Review in Albania: Antiretroviral therapy and procurement and supply management

J. V. Lazarus; M. Gottfredsson; N. Tavagnutti World Health Organization (Europe); Centre for Health & Infectious Disease Research (2015) C_WHO
March 2015
 Add to my MEDBOX

Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis

José A. Caminero International Union Against Tuberculosis and Lung Disease (The Union) (2013)
 Download
  View PDF
 Add to my MEDBOX

The Logistics Handbook - A Practical Guide for the Supply Chain Management of Health Commodities

USAID USAID (2011)
 Download
  View PDF
 Add to my MEDBOX

Maintaining a safe and adequate blood supply during Zika virus outbreaks

World Health Organization WHO (2016) C_WHO
Inerim Guidance. These guidelines have been developed in recognition that infection with Zika virus may present a risk to blood safety, and in consideration of the declaration on 1 February 2016 by the WHO Director-General of a Public Health Emergency of International Concern with regard to clusters ... more
 Download
  View PDF
 Add to my MEDBOX

Field Guide for the Management of Drug-Resistant Tuberculosis
recommended

A. Piubello The International Union Against Tuberculosis and Lung Disease (2018)
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
 Download
  View PDF
 Add to my MEDBOX

Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation

European Monitoring Centre for Drugs and Drug Addiction (2018) C2
An update from the EU Early Warning System
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis. If no action is taken - warns the UN Ad hoc Interagency Coordin ... more
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections. Summary of recommendations and key messages

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
 Download
  View PDF
 Add to my MEDBOX

The Public Health Dimension of the World Drug problem

World Health Organization WHO (2019) C_WHO
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
 Download
  View PDF
 Add to my MEDBOX

Survey on human resource capacity in public health - Supply chain management in Burkina Faso

Bioforce Development Institute – Burkina Faso Country Survey (2011) C2
This survey is part of a series of eight country surveys conducted in the context of the People that Deliver Initiative (peoplethatdeliver.org). This global initiative, which brings together the world’s largest organizations, aims to improve health services performance through the professionalizat ... more
 Add to my MEDBOX

Considerations for introducing new antiretroviral drug formulations for children

World Health Organization WHO (2020) CC
Policy brief. July 2020
 Download
  View PDF
 Add to my MEDBOX

COVID-19 Guidelines Module 5 - Drug therapy

National Department of Health, South Africa NDoH South Africa (2021) CC
 Download
  View PDF
 Add to my MEDBOX

Strategy to respond to antimalarial drug resistance in Africa

World Health Organization WHO (2022) C_WHO
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial ... more
 Download
  View PDF
 Add to my MEDBOX

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended

Médecins sans Frontières (2016) C_WHO
4th edition. This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of ... more
 Download
  View PDF
 Add to my MEDBOX

Health Logistics in Nepal Two Decades of Investments in Public Health Supply Chain Management: How Access to Supplies Improved Health Outcomes in Nepal

USAID, Deliver Project (2014) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Approaches for mobile and migrant populations in the context of malaria multi-drug resistance and malaria elimination in the Greater Mekong Subregion

World Health Organization ( WHO), Regional Office for South-East-Asia (2016) C_WHO
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (‎GMS)‎ has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response, ... more
 Download
  View PDF
 Add to my MEDBOX

National Guidelines and Operational Manual for Programmatic Management of Drug Resistant TB (PMDT), 2nd ed.

Government of the People’s Republic of Bangladesh, Directorate General of Health Services (2013) C1
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... more
 Download
  View PDF
 Add to my MEDBOX

Surveillance and outbreak management of water-related infectious diseases associated with water-supply systems

World Health Organization WHO, Regional Office of Europe (2019) CC
 External Link
 Add to my MEDBOX

Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide

World Health Organization WHO; Institutional research information sharing iris (2013) C_WHO
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
 Add to my MEDBOX

Multiple first-line therapies as part of the response to antimalarial drug resistance

World Health Organization WHO (2024) C_WHO
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner ... more
 Add to my MEDBOX

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach

World Health Organization, UNAIDS, United Nations Office on Drugs and Crime (2008)
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
 Download
  View PDF
 Add to my MEDBOX

Framework for the engagement of all health care providers in the management of drug resistant tuberculosis

World Health Organization (2015) C_WHO
The END TB strategy
 Download
  View PDF
 Add to my MEDBOX

Good Practices in strengthening health systems for the prevention and care of Tuberculosis and drug-resistant Tuberculosis

World Health Organization, Europe (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region (2010–2015)

World Health Organization Eastern Mediterranean (2010) C_WHO
 External Link
 Add to my MEDBOX

The 90 90 90 strategy to end the HIV Pandemic by 2030: Can the supply chain handle it?

D. Jamieson; S. E. Kellerman JIAS ( Journal of the International AIDS Society) (2016) C2
Jamieson D and Kellerman S. Journal of the International AIDS Society 2016, 19:20917 http://www.jiasociety.org/index.php/jias/article/view/20917 | http://dx.doi.org/10.7448/IAS.19.1.20917
 Download
  View PDF
 Add to my MEDBOX

TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis

International Council of Nurses (2015) C2
3rd edition.
 Download
  View PDF
 Add to my MEDBOX

Diagnostics Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
 Download
  View PDF
 Add to my MEDBOX

Medicines Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
 Add to my MEDBOX

List of Medicines for Drug Shop , Ethiopia (LMDS)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2012) C1
Fourth edition
 Add to my MEDBOX

List of Medicines for Rural Drug Vendor, Ethiopia (LMRDV)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2011) C1
Fourth edition
 Download
  View PDF
 Add to my MEDBOX

European Union - Overview

Drug War Facts; Common Sense for Drug Policy (2019) C2
Accessed: 28.03.2019
 Download
  View PDF
 Add to my MEDBOX

Ethiopia: Standard Treatment Guidelines for Health Center

Drug Administration and Control Authority of Ethiopia Contents (2014) C1
3rd edition
 Download
  View PDF
 Add to my MEDBOX

Executive Summary - Conclusions and policy implications

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
World Drug Report 2017 -1- Accessed: 14.03.2019
 Add to my MEDBOX

Antimicrobials use, reistance and containment baseline survey (Ethiopia)

Drug Administration and Control Authority of Ethiopia , et al. (2009) C1
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug ... more
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - Part 1

National Drug Authority (NDA), Uganda (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Perspectives on Drugs - Cocaine trafficking to Europe

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
 Download
  View PDF
 Add to my MEDBOX

Bad Bug Book

Food and Drug Administration (FDA) (2013)
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
 Add to my MEDBOX

Survey of Adherence to Antiretroviral Medicine inEthiopia

Ethiopian Drug Administration and Control Authority (DACA); et al. USAID (2007) C1
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - ANNEXES

National Drug Authority (NDA), Uganda (2017) C1
Doc. No.: INS/GDL/001-(Annexes)
 Download
  View PDF
 Add to my MEDBOX

Changes in Europe’s cannabis resin market

European Monitoring Centre for Drugs and Drug Addiction (2017) C2
Perspectives on Drugs
 Download
  View PDF
 Add to my MEDBOX

Ethiopia: Pharmaceutical Procurement List

Pharmaceuticals and Supply Agency; Ministry of Health Ethiopia (2018) C1
 Download
  View PDF
 Add to my MEDBOX

Comparative Study of Pharmaceutical Waste Disposal in Ethiopia, Kenya, Sudan and Uganda

Iosue, S. PSA Tansforming The Supply Chain (2020) C1
 Add to my MEDBOX

Risk management Plan Guideline for COVID-19 Vaccines

Ethiopian Food and Drug Authority (2021) CC
July 2021
 Add to my MEDBOX

Maldives National Action Plan for Containment of Antimicrobial Resistance 2017-2022

Maldives Food and Drug Authority Ministry of Health (2017) C2
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products Bangladesh

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Registration Guidelines for Medical Devices Bangladesh 2015

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

List of Registered Medical Device for Import

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Strategies to prevent diversion of opioid substitution treatment medications

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspectives on Drugs
 Download
  View PDF
 Add to my MEDBOX

EMCDDA Monographs

T. Rhodes; D. Hedrich European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Harm reduction: evidence, impacts and challenges -10-
 Download
  View PDF
 Add to my MEDBOX

Ukraine country overview

European Monitoring Centre for Drugs and Drug Addiction (2019) C2
Accessed: 22.03.2019
 Download
  View PDF
 Add to my MEDBOX

Moldova country overview

European Monitoring Centre for Drugs and Drug Addiction (2019) C2
Accessed: 28.03.2019
 Download
  View PDF
 Add to my MEDBOX

Country overview: Kazakhstan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Montenegro country overview

J. Sekulić European Monitoring Centre for Drugs and Drug Addiction (2011) C2
A summary of the national drug situation
 Download
  View PDF
 Add to my MEDBOX

North Macedonia

L. Savikj European Monitoring Centre for Drugs and Drug Addiction (2013) C2
A summary of the national drug situation
 Download
  View PDF
 Add to my MEDBOX

New heroin-assisted treatment - Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond

J. Strang; T. Groshkova; N. Metrebian European Monitoring Centre for Drugs and Drug Addiction; Publications Office (2019) C2
EMCDDA Insights - 11 Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Trends in heroin use in Europe — what do treatment demand data tell us?

European Monitoring Centre for Drugs and Drug Addiction (2019) C2
Analysis Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Country overview: Kyrgyzstan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Country overview: Georgia

J.D. Javakhishvili; L. Sturua; I. Kirtadze; et al. European Monitoring Centre for Drugs and Drug Addiction (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Kosovo* country overview

A. Smajljaj European Monitoring Centre for Drugs and Drug Addiction (2013) C2
A summary of the national drug situation
 Download
  View PDF
 Add to my MEDBOX

Market Analysis of synthetic drugs

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
Amphetamine-type stimulants, new psychoactive substances -4- World Drug Report 2017 Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Market Analysis of plant-based drugs

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
Opiates, cocaine, cannabis World Drug Report 2017 -3- Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

HIV in prisons Situation and needs assessment toolkit

United Nations Office4 on Drugs and Crime; European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Advance copy.
 Download
  View PDF
 Add to my MEDBOX

Project Bridge: Differentiation of HIV Services for PWID in Harm Reduction Programs in Kazakhstan

Columbia Social Intervention Group; BRIGE; Consortium of Universities for Global Health; National Institute on Drug Abuse (2019) C2
Nabila El-Bassel, PhD Columbia University @NabilaElBassel #CUGH2018 Accessed: 26.09.2019
 Download
  View PDF
 Add to my MEDBOX

Prevention and control of blood- borne viruses in prison settings

European Centre for Disease Prevention and Control; European Monitoring Centre for Drugs and Drug Addiction (2018) C2
Guidance Brief Selected findings from ECDC and EMCDDA scientific guidance, 2018
 Download
  View PDF
 Add to my MEDBOX

Sharing simple facts. Useful information about menstrual health and hygiene

Government of India, Ministry of Rural Development, Dept. of Drinking water supply (2008) C1
This guidance booklet on Menstrual Hygiene Management (MHM) is intended for adolescent girls and young women. Issues associated with menstruation are never discussed openly and the silence surrounding menstruation burdens young girls by keeping them ignorant of this biological function. Even after t ... more
 Download
  View PDF
 Add to my MEDBOX

Primary health care list

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (1993) C1
 External Link
 Add to my MEDBOX

Essential Package of Health Services (EPHS). Secondary & Tertiary Care: The District, County & National Health Systems (Liberia)
recommended

Ministry of Health & Social Welfare, Liberia (2011) C1
Essential Drug list on page 36!!
 Download
  View PDF
 Add to my MEDBOX

Drugs and age - Drugs and associated issues among young people and older people

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -4-
 Download
  View PDF
 Add to my MEDBOX

HEARTS. Technical package for cardiovascular disease management in primary health care. Access to essential medicines and technology

World Health Organization WHO, et al. (2018) C_WHO
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of ... more
 Add to my MEDBOX

A practical handbook on the pharmacovigilance of antiretroviral medicines

World Health Organization WHO (2013) C_WHO
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica ... more
 External Link
 Add to my MEDBOX

Making products available among community health workers

Chandani, Y.; S. Andersson, A. Heaton, et al. (2014) CC
Evidence for improving community health supply chains from Ethiopia, Malawi and Rwanda. Journal of Global Health vol. 4 No.2 (2014)
 Download
  View PDF
 Add to my MEDBOX

Botswana: Guidelines on Good Manufacturing Practices

Ministry of Health, Gabarone, Botswana (2009) C2
Drug Advisory Board
 Download
  View PDF
 Add to my MEDBOX

ASHP Technical Assistance Bulletin on Compounding Nonsterile Products in Pharmacies

American Society of Hospital Pharmacists (ASHP) ASHP (1994) CC
Drug Distribution and Control: Preparation and Handling This Technical Assistance Bulletin is intended to assist pharmacists in the extemporaneous compounding of non-sterile drug products for ... more
 Download
  View PDF
 Add to my MEDBOX

Kenya Essential Medicines List 2019
recommended

Ministry of Health, Kenya (2019) C1
The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and medicines supply managers in the public and non-pu ... more
 Download
  View PDF
 Add to my MEDBOX

Treatment of tuberculosis - Annex 4 Evidence- to- decision tables

World Health Organization (2017) C_WHO
Guidelines for treatment of drug-susceptible tuberculosis and patient care Update 2017
 Download
  View PDF
 Add to my MEDBOX

Technical update on treatment optimization: use of efavirenz during pregnancy: a public health perspective

World Health Organization (2012) C_WHO
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ ... more
 External Link
 Add to my MEDBOX

Handbook of Humanitarian Health Care Logistics 2nd edition

McGuire, George (2011) CC
Handbook of HUMANITARIAN HEALTH CARE LOGISTICS Designing the Supply Network and Managing the Flows of Information and Health Care Goods in Humanitarian Assistance during Complex Political Emergencies
 Download
  View PDF
 Add to my MEDBOX

Understanding the Antibiotic Manufacturing Ecosystem

Wellcome Trust; Boston Consulting Group (2022) CC
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
 Add to my MEDBOX

Management of MDR-TB: A field guide

Partners in Health, World Health Organization (2009) C_WHO
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) increasingly occur in resource-constrained settings. In the context of a national response to MDR- and XDR-TB, health workers in TB clinics (in distric ... more
 Download
  View PDF
 Add to my MEDBOX

Health Systems in Action: An eHandbook for Leaders and Managers - CHAPTER 8 - Managing Medicines And Health Products

Malcolm Clark; Andy Barraclough Management Sciences for Health (2010) C1
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, whi ... more